Aspen RxHealth operates a clinical pharmacy services marketplace that intelligently matches pharmacists with patients using social and clinical factors. The company says its community includes more than 5,000 pharmacists, which it describes as the largest in the nation. Aspen positions its model to deliver value to health plans and other risk-bearing providers and to enrich the patient–pharmacist experience. Management plans to scale the marketplace rapidly, pursue broader markets such as specialty pharmacy support and medication reconciliation, and capitalize on increased demand for virtual care. The company framed the offering as a new clinical pharmacy services model developed by pharmacists for pharmacists and led by CEO David Medvedeff. Aspen RxHealth is a Tampa, FL–based developer of an app-based intervention platform that connects pharmacists with patients to deliver clinical services, including medication therapy management (MTM). Its offering includes a mobile app and a full technology platform that ensure quality assurance through pharmacist on-boarding and oversight of all patient interactions. The company intends to use the new funding to accelerate development of its technology platform and to add talent. Aspen RxHealth is led by CEO David Medvedeff. The article does not disclose revenues, users, or other operating metrics. The company focuses on improving clinical service delivery via pharmacist-led interventions through its technology.

Total raised

$32M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2021